The Gaithersburg biotech has had no product to market in its 35-year history.
{iframe}https://www.bizjournals.com/washington/news/2022/06/09/novavax-covid-vaccine-stanley-erck-fda.html{/iframe}
The Gaithersburg biotech has had no product to market in its 35-year history.